Undisclosed · Other round · Healthtech · London, UK
London-based personalised wellbeing platform Healf has secured an undisclosed minority investment led by SEMCAP Beauty & Wellness, with participation from Pentland Ventures, Ami Capital, IRIS, Active Partners, Sequel, Dara5, Claudia Schiffer, Natalia Vodianova Arnault and more than 40 athletes, including Reece James and Trevoh Chalobah. The investor announcement says the capital will fund continued platform development and international expansion after Healf's launch in Germany; transaction counsel Davis Polk confirms that financial terms were not disclosed.
Turning a wellness catalogue into a decision layer
Healf began as a curated commerce platform, but its product is moving beyond merchandising. The company says it combines selected products with blood biomarkers, wearable data, practitioner guidance and customer information across four areas: Eat, Move, Mind and Sleep. That creates a route from an initial purchase to a more personalised recommendation loop, rather than leaving customers to navigate supplements, diagnostics and devices as separate categories.
The commercial mechanism is trust reinforced by data. Healf describes a three-step curation process covering brand selection, expert review and community testing, while its diagnostic and wearable inputs are intended to make recommendations more specific to the individual. If that combination works, curation can lower decision friction and give Healf reasons to maintain a relationship beyond a single transaction. It also raises the execution bar: recommendations need to remain credible as the catalogue and data sources expand, because the platform's value depends on customers believing that selection is useful rather than merely promotional.
International growth tests whether the model travels
The financing announcement says Healf has surpassed £100m in annualised revenue with fewer than 100 employees. The company, founded in 2020, was also ranked first in the Financial Times' 2026 FT1000 list by compound annual growth. These are company and investor-reported indicators of scale, not proof that the personalisation layer already drives the business.
Germany is the first market outside the UK and therefore a practical test of whether Healf can reproduce both sides of its proposition: local access to trusted brands and a consistent data-led customer experience. The new capital backs that rollout alongside further platform development. Success would make Healf more than a cross-border wellbeing retailer; it would show that its combination of commerce, diagnostics and guidance can become repeatable infrastructure for choosing among a crowded set of health products.
